Eric Ostertag

2020

In 2020, Eric Ostertag earned a total compensation of $858.7K as Executive Chairman and former Chief Executive Officer at Poseida Therapeutics.

Compensation breakdown

Non-Equity Incentive Plan$301,460
Salary$548,115
Other$9,102
Total$858,677

Ostertag received $548.1K in salary, accounting for 64% of the total pay in 2020.

Ostertag also received $301.5K in non-equity incentive plan and $9.1K in other compensation.

Rankings

In 2020, Eric Ostertag's compensation ranked 9,221st out of 13,090 executives tracked by ExecPay. In other words, Ostertag earned more than 29.6% of executives.

ClassificationRankingPercentile
All
9,221
out of 13,090
30th
Division
Manufacturing
3,940
out of 5,618
30th
Major group
Chemicals And Allied Products
1,601
out of 2,251
29th
Industry group
Drugs
1,400
out of 1,951
28th
Industry
Biological Products, Except Diagnostic Substances
329
out of 411
20th
Source: SEC filing on April 27, 2022.

Ostertag's colleagues

We found two more compensation records of executives who worked with Eric Ostertag at Poseida Therapeutics in 2020.

2020

Mark Gergen

Poseida Therapeutics

Chief Executive Officer

2020

Matthew Spear

Poseida Therapeutics

Chief Medical Officer

News

You may also like